Skip to Main Content

Advertisement

Skip Nav Destination

The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer Subjects

Clin Cancer Res (2016) 22 (22): 5472–5479.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Paulien Ravenstijn
  • Manoranjenni Chetty
  • Pooja Manchandani
  • Mohamed Elmeliegy
  • Hisham Qosa
  • Islam Younis
Clinical and Translational Science (2023) 16 (1): 50.
  • Emilia URRUTIA-MALDONADO
  • María ALÉS-PALMER
  • Paloma MUÑOZ DE RUEDA
  • Irene PELÁEZ-PLEGUEZUELOS
  • Esther OCETE-HITA
Minerva Pediatrics (2023) 75 (5)
  • Anders Soehoel
  • Malte Selch Larsen
  • Stine Timmermann
Clinical Pharmacology in Drug Development (2022) 11 (8): 910.
  • Hamim Zahir
  • Jonathan Greenberg
  • Ching Hsu
  • Thomas C. Marbury
  • Kenneth C. Lasseter
  • Li‐An Xu
  • William D. Tap
  • John H. Healey
  • Silvia Stacchiotti
  • Frank LaCreta
The Journal of Clinical Pharmacology (2022) 62 (8): 992.
  • Philip James Johnson
  • David J. Pinato
  • Anton Kalyuzhnyy
  • Hidenori Toyoda
Journal of Clinical Oncology (2022) 40 (19): 2078.
  • Ophelia Yin
  • Yuan Xiong
  • Seiko Endo
  • Kazutaka Yoshihara
  • Tushar Garimella
  • Malaz AbuTarif
  • Russ Wada
  • Frank LaCreta
Clinical Pharmacology & Therapeutics (2021) 109 (5): 1314.
  • Nadia Terranova
  • Mendel Jansen
  • Martin Falk
  • Bart S. Hendriks
Cancer Chemotherapy and Pharmacology (2021) 87 (2): 185.
  • Ophelia Yin
  • Andrew J. Wagner
  • Jia Kang
  • William Knebel
  • Hamim Zahir
  • Michiel van de Sande
  • William D. Tap
  • Hans Gelderblom
  • John H. Healey
  • Dale Shuster
  • Silvia Stacchiotti
The Journal of Clinical Pharmacology (2021) 61 (4): 480.
  • Sebastian P. Mondaca
  • Dazhi Liu
  • Jessica R. Flynn
  • Sandy Badson
  • Stefan Hamaway
  • Mrinal M. Gounder
  • Danny N. Khalil
  • Alexander E. Drilon
  • Bob T. Li
  • Komal L. Jhaveri
  • Alison M. Schram
  • Katherine E. Kargus
  • Mary Kate Kasler
  • Natalie M. Blauvelt
  • Neil H. Segal
  • Marinela Capanu
  • Margaret K. Callahan
  • David M. Hyman
  • Maya Gambarin‐Gelwan
  • James J. Harding
Cancer (2020) 126 (22): 4967.
  • Xiaofei Zhou
  • A. Craig Lockhart
  • Siqing Fu
  • John Nemunaitis
  • John Sarantopoulos
  • Andreas Muehler
  • Lakshmi Rangachari
  • Michael Bargfrede
  • Karthik Venkatakrishnan
The Journal of Clinical Pharmacology (2019) 59 (9): 1204.
  • Enrique Grande
  • R. Donald Harvey
  • Benoit You
  • Jaime Feliu Batlle
  • Hal Galbraith
  • John Sarantopoulos
  • Suresh S. Ramalingam
  • Helen Mann
  • Karen So
  • Martin Johnson
  • Karthick Vishwanathan
Journal of Pharmacology and Experimental Therapeutics (2019) 369 (2): 291.
  • Emilia Urrutia-Maldonado
  • Ana Abril-Molina
  • María Alés-Palmer
  • Jose María Gómez-Luque
  • Paloma Muñoz de Rueda
  • Esther Ocete-Hita
Anales de Pediatría (English Edition) (2019) 91 (4): 256.
  • Stefanie D Krens
  • Gerben Lassche
  • Frank G A Jansman
  • Ingrid M E Desar
  • Nienke A G Lankheet
  • David M Burger
  • Carla M L van Herpen
  • Nielka P van Erp
The Lancet Oncology (2019) 20 (6): e290.
  • Emilia Urrutia-Maldonado
  • Ana Abril-Molina
  • María Alés-Palmer
  • Jose María Gómez-Luque
  • Paloma Muñoz de Rueda
  • Esther Ocete-Hita
Anales de Pediatría (2019) 91 (4): 256.
  • Stefanie D Krens
  • Gerben Lassche
  • Frank G A Jansman
  • Ingrid M E Desar
  • Nienke A G Lankheet
  • David M Burger
  • Carla M L van Herpen
  • Nielka P van Erp
The Lancet Oncology (2019) 20 (4): e200.
  • Stephanie Faucette
  • Santosh Wagh
  • Ashit Trivedi
  • Karthik Venkatakrishnan
  • Neeraj Gupta
Clinical and Translational Science (2018) 11 (2): 123.
  • Christos Fountzilas
  • Selena Stuart
  • Brian Hernandez
  • Elizabeth Bowhay-Carnes
  • Joel Michalek
  • John Sarantopoulos
  • Anand Karnad
  • Sukeshi Patel
  • Steven Weitman
  • Devalingam Mahalingam
Investigational New Drugs (2017) 35 (3): 386.
Close Modal

or Create an Account

Close Modal
Close Modal